AMEDICA Corp

SALT LAKE CITY, UT · Medtech · Acquired

Silicon carbide spinal implants and fusion systems

Claim this profile

Follows are private to you and power your alerts

Updated · ctlamedica.com

Sector
Medtech
Headquarters
SALT LAKE CITY, UT
Latest Form D
$5.5M, Jul 2014
Total capital
$63.8M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$63.8M
7 Form D · last Jul 2014
147 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

20102011201220132014FEDERAL ↑EQUITY ↓Cumulative $63.8M3rd Form D$22.1M6th Form D$7.5M7th Form D$5.5M
20102011201220132014FEDERAL ↑EQUITY ↓Cumulative $63.8M3rd Form D$22.1M

Latest events

  • Private capital raisedForm D · SEC · 7th filing$5.5M
  • Private capital raisedForm D · SEC · 6th filing$7.5M
  • Private capital raisedForm D · SEC · 5th filing$3.1M
  • Private capital raisedForm D · SEC · 4th filing$540K
  • Private capital raisedForm D · SEC · 3rd filing$22.1M
  • Private capital raisedForm D · SEC · 2nd filing$13.6M
  • Private capital raisedForm D · SEC · 1st filing$11.4M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Ashok R. KhandkarExecutive Officer, DirectorNamed in SEC Form D filings
  • Ben R. ShappleyExecutive Officer, DirectorNamed in SEC Form D filings
  • Bryan J. McEntireExecutive OfficerNamed in SEC Form D filings
  • B. Sonny M BalDirectorNamed in SEC Form D filings
  • Christopher R. WhitfieldExecutive OfficerNamed in SEC Form D filings
  • David W TreutzelDirectorNamed in SEC Form D filings
Show all 25 people
  • David E TruetzelDirectorNamed in SEC Form D filings
  • Eric K. OlsonExecutive Officer, DirectorNamed in SEC Form D filings
  • F. Karl J. FarnsworthExecutive OfficerNamed in SEC Form D filings
  • George M. SingerDirectorNamed in SEC Form D filings
  • Gregg R. HonigblumDirectorNamed in SEC Form D filings
  • James P AbrahamExecutive Officer, DirectorNamed in SEC Form D filings
  • Jay M. MoyesDirectorNamed in SEC Form D filings
  • Jeffrey S WhiteDirectorNamed in SEC Form D filings
  • Jonathan StupkaExecutive OfficerNamed in SEC Form D filings
  • Karl M. FarnsworthExecutive OfficerNamed in SEC Form D filings
  • Ken EakinExecutive OfficerNamed in SEC Form D filings
  • Kevin J. DavisExecutive OfficerNamed in SEC Form D filings
  • Kevin J. OntiverosExecutive OfficerNamed in SEC Form D filings
  • Max K. LinkDirectorNamed in SEC Form D filings
  • Max E Link, Ph.D.Executive Officer, DirectorNamed in SEC Form D filings
  • Reyn GallacherExecutive OfficerNamed in SEC Form D filings
  • Rohit R. PatelDirectorNamed in SEC Form D filings
  • Sonny K. BalDirectorNamed in SEC Form D filings
  • Vytas J RupinskasExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

  • NEUROINDX INC.Similar federal contract value in Medtech · null in contracts
  • Sonova Holding AGSimilar federal contract value in Medtech · null in contracts
  • GENOMATE HEALTH, INC.Similar federal contract value in Medtech · null in contracts
  • Solenic Medical IncSimilar federal contract value in Medtech · null in contracts
  • Qualia, Inc.Similar federal contract value in Medtech · null in contracts
  • SILICON AUDIO, LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .